Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions


Latest Cancer News

Viagra Associated with Increased Risk of Melanoma (April 18, 2014)

Men who take by Viagra (sildenafil) are 84 percent more likely to develop melanoma than men who do not, according to the results of a study published in JAMA Internal Medicine. Melanoma is a potentially... Continue Reading

Vegetarian Diet Linked to Poor Health (April 17, 2014)

A vegetarian diet may be linked to a lower body mass index (BMI) and less frequent alcohol consumption; however, it also appears to be associated with poorer health, a higher need for health care, and... Continue Reading

Jakafi Prolongs Survival in Primary Myelofibrosis (April 16, 2014)

Jakafi® (ruxolitinib) prolongs survival in patients with intermediate- or high-risk primary myelofibrosis compared with patients who receive conventional therapy, according to the results of a study published... Continue Reading

Avastin Plus Chemotherapy Improves Progression-Free Survival in Platinum-Resistant Recurrent Ovarian Cancer (April 9, 2014)

The addition of Avastin® (bevacizumab) to standard chemotherapy significantly improved progression-free survival and objective response rate among women with platinum-resistant recurrent ovarian cancer,... Continue Reading

Have a Question about Breast Cancer, Diet and Exercise? Join us on May 7 and 8 (April 9, 2014)

CancerConnect and Dana-Farber Cancer Institute Present: Ask the Expert with Dr. Ligibel CancerConnect has partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert,... Continue Reading

Post-Mastectomy Radiation Beneficial for Cancer That Has Spread to Only a Few Lymph Nodes (April 8, 2014)

Women whose breast cancer has spread to just a few lymph nodes are less likely to experience recurrence or die from their disease if they undergo radiation therapy after mastectomy, according to the results... Continue Reading

Updated Guidelines for Sentinel Node Biopsy in Early Stage Breast Cancer (April 2, 2014)

The American Society of Clinical Oncology (ASCO) has issued new recommendations for the use of sentinel lymph node biopsy in patients with early stage breast cancer. The guidelines were published online... Continue Reading

Web Chat on “Using Radiation to Treat Colorectal Cancers Metastasized to the Liver,” with Sarah Cannon Expert Andrew Kennedy, MD (April 2, 2014)

  Sarah Cannon Radiation Oncology Physician-in-Chief Andrew Kennedy, MD, discusses metastatic colorectal cancer and answers participants’ questions during a live Web chat recorded on April 2, 2014.... Continue Reading

Ceritinib Highly Active in Advanced ALK-Positive NSCLC (April 1, 2014)

The investigational compound ceritinib (LDK378) was highly active in patients with advanced ALK-positive non-small cell lung cancer, according to the results of a study published in the New England Journal... Continue Reading

T-VEC Vaccine Promotes Tumor Shrinkage in Advanced Melanoma (March 28, 2014)

The experimental cancer vaccine talimogene laherparepvec (T-VEC) promoted tumor shrinkage and triggered a systemic immune response in patients with advanced melanoma, according to the results of a study... Continue Reading

Multiple Myeloma Q&A with Roswell Park Cancer Institute Expert (March 27, 2014)

CancerConnect recently partnered with Roswell Park Cancer Institute to provide you with the opportunity to engage with a multiple myeloma expert, Sarah Holstein, MD, PhD. Dr. Holstein was a guest moderator... Continue Reading

New Guidelines Could Add 12.8 Million New Statin Users (March 26, 2014)

The new American College of Cardiology–American Heart Association (ACC-AHA) guidelines for managing cholesterol—if adhered to strictly—would increase the number of adults eligible for statin therapy... Continue Reading

Fertility Concerns Affect Treatment Decisions in Younger Women with Breast Cancer (March 26, 2014)

Fertility concerns affect treatment decisions in a substantial proportion of young women with breast cancer; however, few women pursue available fertility preservation strategies, according to the results... Continue Reading

No Significant Bone Density Differences Between Aromasin and Arimidex (March 20, 2014)

There was no significant difference in bone mineral density loss among women with early breast cancer treated with adjuvant Aromasin® (exemestane) or Arimidex® (anastrozole), according to the results... Continue Reading

Radical Prostatectomy Shows Significant Long-Term Benefit in Early Prostate Cancer (March 18, 2014)

Extended follow-up of the Scandinavian Prostate Cancer Group-4 trial (SPCG-4) has confirmed that radical prostatectomy is associated with a substantial reduction in mortality among men with early prostate... Continue Reading

Nivolumab Produces Durable Responses in Advanced Melanoma (March 14, 2014)

Nivolumab, an investigational, anti–PD-1 drug, produced durable responses in patients with advanced melanoma, according to the results of a study published in the Journal of Clinical Oncology. Of the... Continue Reading

Mastectomy May Be Unnecessary in Stage IV Breast Cancer (March 13, 2014)

Mastectomy is unnecessary in many women with stage IV breast cancer—and in fact may even facilitate the spread of the disease, according to the results of a study presented at the 2013 San Antonio Breast... Continue Reading

Jakafi Safe and Effecitve in Polycythemia Vera (March 11, 2014)

The results from a Phase III clinical trial indicate that Jakafi® (ruxolitinib) controlled hematocrit levels and reduced spleen size by 35 percent or more among patients with polycythemia vera. Myeloproliferative... Continue Reading

Treanda/Velcade/Dexamethasone Produces High Response Rate in Relapsed/Refractory Multiple Myeloma (March 10, 2014)

The combination of Treanda® (bendamustine), Velcade® (bortezomib) and dexamethasone produced a high response rate in patients with relapsed/refractory multiple myeloma, according to the results of a... Continue Reading

Revlimid Linked with Second Primary Malignancies in Patients with Myeloma (March 7, 2014)

Revlimid® (lenalidomide)—particulary when used in combination with oral melphalan—is associated with an increased risk of second primary malignancies in patients with myeloma, according to the results... Continue Reading

Nintedanib Plus Docetaxel is Effective Second-Line Therapy for NSCLC (March 6, 2014)

Nintedanib in combination with docetaxel is an effective second-line option for patients with advanced non-small cell lung cancer previously treated with one line of platinum-based therapy, according to... Continue Reading

Predicting SIR-Spheres® microspheres Treatment Outcomes for Metastatic Colorectal Cancer (March 5, 2014)

Pre-treatment laboratory tests may play a key role in predicting patient outcomes prior to selective internal radiation therapy for metastatic colorectal cancer, while a new modeling technology for enhancing... Continue Reading

Continuous Revlimid/Lose-Dose Dexamethasone Improves Outcomes in Newly Diagnosed Multiple Myeloma (March 3, 2014)

Among people with newly diagnosed multiple myeloma who are ineligible for stem cell transplantation, continuous treatment with Revlimid® (lenalidomide) and low-dose dexamethasone results in better overall... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions

Cancer Types

Headline News by Cancer Type

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS